- Abdullah Ibrahim Al Yousef resigns from Lana Medical's Audit Committee for personal reasons.
- Faisal Ayedh Al Nufaie is appointed as a new independent member of the committee.
- Governance Committee functions are consolidated into the Audit Committee's expanded mandate.

Lana Medical Company recently announced a significant restructuring of its Audit Committee following the resignation of Abdullah Ibrahim Al Yousef, a key member of the committee, citing personal reasons. Al Yousef's resignation, effective 24 June 2026, prompted the Board of Directors to appoint Faisal Ayedh Al Nufaie as a new independent member. As part of the restructuring, the Governance Committee functions have been consolidated into the expanded mandate of the Audit Committee.

Al Yousef, who began his tenure on 9 December 2024, submitted his resignation on 24 June 2026, with the board accepting the decision to take immediate effect. To fill the vacancy, Al Nufaie was appointed as an independent member from outside the Board of Directors, bringing valuable expertise in corporate governance and economic law to Lana Medical Company.

Al Nufaie, a veteran of the Saudi financial and corporate sectors, has held prominent leadership roles at institutions like Al Rajhi Bank and Banque Saudi Fransi. His appointment aims to enhance the oversight framework of Lana Company and maintain high standards of transparency and institutional discipline. The company has dissolved its Governance Committee, transferring all responsibilities to the newly constituted Audit Committee, which now comprises four members including Al Nufaie. This strategic move to streamline internal controls and oversight mechanisms reflects Lana Medical's commitment to efficient corporate management.